A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/09/1998	CN1041096C Fluorinated 17 beta-substituted 4-aza-5 alpha-androstane-3-one derivatives
12/09/1998	CN1041095C Steroid compounds for treatment of prostatic hypertrophy, and its medicinal composition thereof
12/09/1998	CN1041094C Lobaplatin-trihydrat, its preparation method and use
12/09/1998	CN1041091C Trisubstituted pyrimido (5,4-d) pyrimidines for modulating multi-medicine resistance, medicinal composition containing said compound and preparation
12/09/1998	CN1041090C Pyridopyrimidine derivatives, their production and use
12/09/1998	CN1041088C Optically active imidazolizone derivative and medicinal composition for treating dementia
12/09/1998	CN1041087C Arylacetamides, preparation method and use thereof
12/09/1998	CN1041054C Method for preparing medicine composition containing steroid 5-alpha-reductase inhibitors
12/09/1998	CN1041053C Use of medicine of imidazole-1-yl chemical compound
12/09/1998	CA2231015A1 Novel compounds
12/08/1998	USRE35985 Fungicidal compositions
12/08/1998	US5847172 Certain aminosterol compounds and pharmaceutical compositions including these compounds
12/08/1998	US5847164 Method for the preparation of chromanone 7
12/08/1998	US5847159 1- ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
12/08/1998	US5847155 Aromatic pyrrolidine amide prolyl endopeptidase inhibitors
12/08/1998	US5847152 Preparation of a D-(+)-biotin intermediate
12/08/1998	US5847151 Gaba and L-glutamic acid analogs for antiseizure treatment
12/08/1998	US5847127 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
12/08/1998	US5847124 Hydrated forms of zilpatherol hydrochloride
12/08/1998	US5847119 2-bromo-and derivatives of 3-bromo-and 3,3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof
12/08/1998	US5847114 Poly-substituted phthalocyantines
12/08/1998	US5847109 Galactomannan products and compositions containing the same
12/08/1998	US5847107 Method of preparing mixed glucosamine salts
12/08/1998	US5847106 Monomeric and dimeric nucleosides with silyl-containing diamino phosphorous linkages
12/08/1998	US5847092 Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity
12/08/1998	US5847010 Treatment of multiple sclerosis
12/08/1998	US5847009 Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
12/08/1998	US5847008 Method of treating diabetes and related disease states
12/08/1998	US5847007 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/08/1998	US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998	US5847003 Oxa acids and related compounds for treating skin conditions
12/08/1998	US5847000 Fatty acid derivatives
12/08/1998	US5846998 Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
12/08/1998	US5846996 Topical ascorbic acid compositions
12/08/1998	US5846992 Synergistic intraocular pressure lowering combinations
12/08/1998	US5846990 Substituted biphenyl isoxazole sulfonamides
12/08/1998	US5846989 Benzothiazolone derivatives
12/08/1998	US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998	US5846987 Retroviral protease inhibiting compounds
12/08/1998	US5846984 Use of ciclopirox or a pharmaceutically acceptable salt thereof for inhibiting neuronal cell damage or neuronal cell death
12/08/1998	US5846983 Colonic delivery of nicotine to treat inflammatory bowel disease
12/08/1998	US5846982 Inhibition of serotonin reuptake
12/08/1998	US5846981 Inhibitors of rotamase enzyme activity
12/08/1998	US5846979 N-oxides of heterocyclic esters, amides, thioesters, and ketones
12/08/1998	US5846977 Nerve growth factor production accelerators and compositions for preventing or treating neuronal degeneration
12/08/1998	US5846976 Androstenone derivative
12/08/1998	US5846975 Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/08/1998	US5846974 Method for treating substance abuse withdrawal
12/08/1998	US5846973 Methods of treating pulmonary hypertension
12/08/1998	US5846972 Bicyclic pyrimidine derivatives and their use as anti-coagulants
12/08/1998	US5846971 Oral antifungal composition
12/08/1998	US5846970 Bicyclic pyrimidine derivatives and their use as anti-coagulants
12/08/1998	US5846968 N-substituted azaheterocyclic carboxylic acids and esters
12/08/1998	US5846967 Natriuretic and anti-hypertensive compounds
12/08/1998	US5846966 Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors
12/08/1998	US5846965 3-aza and 3-oxa piperidone tachykinin antagonists
12/08/1998	US5846964 Hepatitis C virus proliferation inhibitor
12/08/1998	US5846963 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/08/1998	US5846962 Anti-obesity agents
12/08/1998	US5846960 Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds
12/08/1998	US5846959 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
12/08/1998	US5846958 Methods of using aminothiols to promote hematopoietic progenitor cell growth
12/08/1998	US5846957 Use of an ester of inositoltrisphosphate for the preparing of medicaments
12/08/1998	US5846954 Cyclodextrin compounds and methods of making and use thereof
12/08/1998	US5846950 Pharmaceutical composition for promoting the proliferation of human corneal endothelium and a method for using thereof
12/08/1998	US5846947 Composition containing nucleic acids, preparation and uses
12/08/1998	US5846944 Purified SDG as an antioxidant
12/08/1998	US5846943 Solid support matricles containing a toxin binding oligosaccharide
12/08/1998	US5846931 Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide and methods of inducing cartilage by administration of same
12/08/1998	US5846825 Feline derived T-cell lines for producing FIV
12/08/1998	US5846806 Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
12/08/1998	US5846766 Oxytocin receptor and DNA coding therefor
12/08/1998	US5846742 Selecting substances for treating glucocorticoid-mediated inflammation or immune diseases using Tripterygium wilfordii Hook F extracts
12/08/1998	US5846572 Body fluid replacement solution
12/08/1998	US5846571 Compositions and methods of combatting fungi
12/08/1998	US5846566 Microcapsules for the controlled release of acetylsalicylic acid in the gastrointestinal environment
12/08/1998	US5846565 Controlled local delivery of chemotherapeutic agents for treating solid tumors
12/08/1998	US5846564 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
12/08/1998	US5846562 Oral composition of fumagillol derivative
12/08/1998	US5846552 Use of 2,4-diaminopyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders
12/08/1998	US5846546 Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
12/08/1998	US5846514 Enhancement of the efficacy of nifedipine by deuteration
12/08/1998	CA2150129C Amino-substituted pyrazoles having crf antagonistic activity
12/08/1998	CA2095439C Substance that stops any bleeding on contact for medical, surgical and dental uses
12/08/1998	CA2073180C Therapeutic uses of melanin
12/08/1998	CA2053209C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
12/08/1998	CA2038935C Biologically active drug polymer derivatives and method for preparing same
12/08/1998	CA2030345C Use of 15-keto-prostaglandin compound for improvement of encephalic function
12/08/1998	CA2026671C 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom
12/08/1998	CA2002106C O-acylated derivatives of 1,5-dideoxy-1, 5-imino-d-glucitol
12/08/1998	CA1340171C Aqueous solution conataing fat-soluble vitamin k
12/03/1998	WO1998054821A1 Brush holder
12/03/1998	WO1998054365A1 Control of immune responses by modulating activity of glycosyltransferases
12/03/1998	WO1998054347A1 Integrin-targeting vectors having transfection activity
12/03/1998	WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998	WO1998054316A1 Sodium channel receptor
12/03/1998	WO1998054313A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998	WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
12/03/1998	WO1998054216A1 Gene and amino acid sequences for novel transcription factor
12/03/1998	WO1998054203A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies

1 ... 6570 6571 6572 6573 6574 6575 6576 6577 6578 6579 6580 6581 6582 6583 6584 6585 6586 6587 6588 6589 6590 ... 7860